Ticker
RGNXCompany Name
REGENXBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 155.78M | $ 36.62M | 23.5% |
3/31/2025 | $ 156.72M | $ 37.4M | 23.86% |
12/31/2024 | $ 83.33M | $ 38.46M | 46.16% |
9/30/2024 | $ 84.33M | $ 37.26M | 44.18% |
6/30/2024 | $ 89.04M | $ 37.59M | 42.22% |
3/31/2024 | $ 86.73M | $ 38.66M | 44.58% |
12/31/2023 | $ 90.24M | $ 40.27M | 44.62% |
9/30/2023 | $ 99.37M | $ 41.34M | 41.6% |
6/30/2023 | $ 96.97M | $ 41.36M | 42.65% |
3/31/2023 | $ 109.64M | $ 41.19M | 37.57% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for REGENXBIO INC is calculated as follows: SB Comp. [ $ 31.24M ] / Revenues [ $ 144.89M ]
(=) SB Comp % [ 21.56% ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 2.99K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |